CTLA-4 is not only associated with glioma progression and prognosis, the CTLA-4 A49G polymorphism might also be a potential clinically relevant biomarker for distinguishing individuals with a high risk for developing glioma (Wu et al., 2011). The gene discussed is CTLA4; the disease is glioma.